| Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms MY Huang, XM Jiang, BL Wang, Y Sun, JJ Lu Pharmacology & therapeutics 219, 107694, 2021 | 98 | 2021 |
| Anticancer drug discovery from Chinese medicinal herbs MY Huang, LL Zhang, J Ding, JJ Lu Chinese medicine 13, 1-9, 2018 | 98 | 2018 |
| Regulation of CD47 expression in cancer cells CY Huang, ZH Ye, MY Huang, JJ Lu Translational oncology 13 (12), 100862, 2020 | 77 | 2020 |
| Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells XM Jiang, YL Xu, MY Huang, LL Zhang, MX Su, X Chen, JJ Lu Acta Pharmacologica Sinica 38 (11), 1512-1520, 2017 | 68 | 2017 |
| Bioactive platycodins from Platycodonis Radix: Phytochemistry, pharmacological activities, toxicology and pharmacokinetics LL Zhang, MY Huang, Y Yang, MQ Huang, JJ Shi, L Zou, JJ Lu Food chemistry 327, 127029, 2020 | 65 | 2020 |
| Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells MY Huang, XM Jiang, YL Xu, LW Yuan, YC Chen, G Cui, RY Huang, B Liu, ... Food and Chemical Toxicology 131, 110537, 2019 | 54 | 2019 |
| TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance X Jiang, Y Xu, L Yuan, L Zhang, M Huang, Z Ye, M Su, X Chen, H Zhu, ... Acta Pharmacologica Sinica 42 (3), 451-459, 2021 | 40 | 2021 |
| Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells LW Yuan, XM Jiang, YL Xu, MY Huang, YC Chen, WB Yu, MX Su, ZH Ye, ... Phytomedicine 80, 153394, 2021 | 39 | 2021 |
| Regulation of CD47 expression by interferon-gamma in cancer cells ZH Ye, XM Jiang, MY Huang, YL Xu, YC Chen, LW Yuan, CY Huang, ... Translational Oncology 14 (9), 101162, 2021 | 28 | 2021 |
| Myricetin inhibits interferon-γ-induced PD-L1 and IDO1 expression in lung cancer cells YC Chen, XL He, L Qi, W Shi, LW Yuan, MY Huang, YL Xu, X Chen, L Gu, ... Biochemical Pharmacology 197, 114940, 2022 | 22 | 2022 |
| Nagilactone E suppresses TGF-β1-induced epithelial–mesenchymal transition, migration and invasion in non-small cell lung cancer cells LL Zhang, XM Jiang, MY Huang, ZL Feng, X Chen, Y Wang, H Li, A Li, ... Phytomedicine 52, 32-39, 2019 | 20 | 2019 |
| Nagilactone E increases PD-L1 expression through activation of c-Jun in lung cancer cells C Yu-Chi, MY Huang, LL Zhang, F Zhe-Ling, XM Jiang, Y Luo-Wei, ... Chinese journal of natural medicines 18 (7), 517-525, 2020 | 16 | 2020 |
| Paraptosis: A non-classical paradigm of cell death for cancer therapy C Xu, Y Lin, M Huang, X Zhang, P Wang, M Huang, J Lu Acta Pharmacologica Sinica 45 (2), 223-237, 2024 | 10 | 2024 |
| Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives ZH Ye, WB Yu, MY Huang, J Chen, JJ Lu Acta Pharmaceutica Sinica B 13 (4), 1467-1487, 2023 | 8 | 2023 |
| Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10 MY Huang, YC Chen, WY Lyu, XY He, ZH Ye, CY Huang, XL He, X Chen, ... Pharmacological Research 198, 106988, 2023 | 7 | 2023 |
| c-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2 MX Su, YL Xu, XM Jiang, MY Huang, LL Zhang, LW Yuan, XH Xu, Q Zhu, ... Acta Pharmaceutica Sinica B 12 (3), 1240-1253, 2022 | 7 | 2022 |
| Glutathione peroxidase 8 expression on cancer cells and cancer‐associated fibroblasts facilitates lung cancer metastasis YL Xu, LW Yuan, XM Jiang, MX Su, MY Huang, YC Chen, LL Zhang, ... MedComm 3 (3), e152, 2022 | 4 | 2022 |
| Identification of AHSA1 as a potential therapeutic target for breast cancer: bioinformatics analysis and in vitro studies W Shi, L Qi, XB You, YC Chen, YL Xu, WB Yu, MY Huang, H Zhao, JJ Lu Current Cancer Drug Targets 22 (2), 142-152, 2022 | 3 | 2022 |
| Immunogenic cell death inducers for cancer therapy: an emerging focus on natural products LL Zhang, DJ Zhang, JX Shi, MY Huang, JM Yu, XJ Chen, X Wei, L Zou, ... Phytomedicine, 155828, 2024 | | 2024 |
| Myricetin inhibits interferon-γ-induced programmed death ligand-1 and indoleamine 2, 3-dioxygenase 1 expression in lung cancer cells YC CHEN, XL HE, L QI, W SHI, LW YUAN, MY HUANG, YL XU, XP CHEN, ... Chinese Journal of Pharmacology and Toxicology, 761-761, 2021 | | 2021 |
Jin-Jian LuUniversity of Macau在 um.edu.mo 的电子邮件经过验证
Jin-Jian LuUniversity of Macau在 um.edu.mo 的电子邮件经过验证
Ting LiUniversity of Macau在 um.edu.mo 的电子邮件经过验证
Jiang Xiao-MingUniversity of Macau